PAPER Grossberg GT, Stahelin HB, Messina JC, Anand R, Veach J

Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications.

Int J Geriatr Psychiatry. 2000 Mar;15(3):242-7. PubMed.

PAPER McIlroy SP, Vahidassr MD, Savage DA, Lloyd F, Patterson CC, Lawson JT, Passmore AP

Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland.

Int J Geriatr Psychiatry. 2000 Mar;15(3):260-6. PubMed.

PAPER Jones-Ritson M, Bullock R

Does oestrogen protect the male brain too? A case of oestrogen withdrawal in a man reveals underlying dementia.

Int J Geriatr Psychiatry. 2000 Mar;15(3):284-5. PubMed.

PAPER Robles A, Touriño R, Gude F, Noya M

The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.

Funct Neurol. 1999 Oct-Dec;14(4):203-7. PubMed.

PAPER Raina AK, Templeton DJ, Deak JC, Perry G, Smith MA

Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease.

Redox Rep. 1999;4(1-2):23-7. PubMed.

PAPER Kaye JA

Methods for discerning disease-modifying effects in Alzheimer disease treatment trials.

Arch Neurol. 2000 Mar;57(3):312-4. PubMed.

PAPER Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J

Diagnostic accuracy of dementia with Lewy bodies.

Arch Neurol. 2000 Mar;57(3):347-51. PubMed.

PAPER Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H

Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.

Biol Psychiatry. 2000 Mar 15;47(6):557-61. PubMed.

PAPER Tanzi RE

Alzheimer's disease risk and the interleukin-1 genes.

Ann Neurol. 2000 Mar;47(3):283-5. PubMed.

PAPER Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, Canal N, Griffin WS, Franceschi M

Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.

Ann Neurol. 2000 Mar;47(3):361-5. PubMed.

PAPER Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS

Association of interleukin-1 gene polymorphisms with Alzheimer's disease.

Ann Neurol. 2000 Mar;47(3):365-8. PubMed.

PAPER Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Förstl H, Maier W, Pauls J, Lautenschlager N, Heun R

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.

Ann Neurol. 2000 Mar;47(3):399-403. PubMed.

PAPER Sommer B, Sturchler-Pierrat C, Abramowski D, Wiederhold KH, Calhoun M, Jucker M, Kelly P, Staufenbiel M

Transgenic approaches to model Alzheimer's disease.

Rev Neurosci. 2000;11(1):47-51. PubMed.

PAPER Perry RJ, Hodges JR

Relationship between functional and neuropsychological performance in early Alzheimer disease.

Alzheimer Dis Assoc Disord. 2000 Jan-Mar;14(1):1-10. PubMed.

PAPER Blass JP, Cyrus PA, Bieber F, Gulanski B

Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group.

Alzheimer Dis Assoc Disord. 2000 Jan-Mar;14(1):39-45. PubMed.